Update shared on03 Oct 2025
Fair value Decreased 2.22%Colgate-Palmolive's analyst price target has been revised downward by approximately $2 to $93. Analysts cite ongoing category headwinds and decelerating growth in the personal care sector as reasons for this adjustment.
Analyst Commentary
Recent analyst commentary on Colgate-Palmolive highlights a balance of optimism for the company’s strategic positioning and concerns over ongoing industry challenges. The following summarizes bullish and bearish perspectives based on the latest research updates.
Bullish Takeaways- Colgate-Palmolive maintains a compelling global footprint, with notable brand strength in key markets such as Latin America. This supports its long-term positioning.
- Bullish analysts point to the company’s robust brand equity and established product categories as drivers of resilience, even as category growth moderates.
- The launch of a new strategic plan through 2030 includes a targeted three-year restructuring program that is expected to enhance supply chain efficiency and streamline operations. This supports future margin improvement.
- Bullish valuation arguments are supported by management’s commitment to cost optimization and operational discipline, which may position Colgate-Palmolive ahead of peers if category growth accelerates.
- Bearish analysts caution that category headwinds are likely to persist in the near term, putting pressure on sales growth and limiting potential upside for the stock price.
- The firm’s updated sales guidance now reflects growth at the lower end of the previously expected range, citing “muted and decelerating” trends in parts of the personal care market.
- Ongoing adjustments to price targets, including multiple downward revisions, signal concern about the company’s ability to deliver above-average growth or re-accelerate revenue in the coming quarters.
- Execution risk remains elevated as Colgate-Palmolive embarks on its restructuring initiatives. These efforts may take time to deliver tangible results and could weigh on margins in the short term.
What's in the News
- Between April and June 2025, Colgate-Palmolive repurchased 2,550,017 shares for $231.16 million, completing a previously announced buyback for a total of 2,834,170 shares and $257.16 million (Key Developments).
- The company has reaffirmed its earnings guidance for 2025, expecting net sales growth in the low single digits. The impact of foreign exchange rates is projected to be flat to slightly negative (Key Developments).
- Colgate-Palmolive projects organic sales growth for 2025 to be at the low end of the 2% to 4% range. This projection factors in the planned exit from private label pet sales (Key Developments).
Valuation Changes
- Fair Value Estimate: Decreased moderately from $95.22 to $93.11, reflecting a reduction of just over $2 per share.
- Discount Rate: Remained unchanged at 6.78%.
- Revenue Growth: Declined slightly from 3.84% to 3.75%.
- Net Profit Margin: Increased modestly from 15.52% to 15.56%.
- Future P/E Ratio: Decreased slightly from 26.08x to 25.51x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.